REFERENCES
- Swofford CD, Scheller-Gilkey G, Miller AH, Woolwine B, Mance R. Double jeopardy: Schizophrenia and substance use. Am J Drug Alcohol Abuse 2000; 26(3):343–353.
- Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO. Cannabis and schizophrenia: Demographic and clinical correlates. Encephale 2003; 29(1):7–11 ( in French).
- Ringen PA, Melle I, Birkenaes AB, Engh JA, Faerden A, Jónsdóttir H, Nesvåg R, Vaskinn A, Friis S, Larsen F, Opjordsmoen S, Sundet K, Andreassen OA. Illicit drug use in patients with psychotic disorders compared with that in the general population. A cross-sectional study. Acta Psychiatr Scand 2008; 117:133–138.
- Turkington A, Mulholland CC, Rushe TM, Anderson R, McCaul R, Barrett SL, Barr RS, Cooper SJ. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psychiatry 2009; 195(3):242–248.
- Volkow N. Substance use disorders in schizophrenia – clinical implications of comorbidity. Schizophr Bull 2009; 35(3):469–472.
- Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiological Catchment Area (ECA) Study. J Am Med Assoc 1990; 264(19):2511–2518.
- Poikolainen K. Huumeet Suomessa: Esiintyvyys ja kustannukset. Duodecim 1998; 114(20):2103 ( in Finnish).
- Nuorvala Y, Metso L, Kaukonen O, Haavisto K. Muuttuva päihdeasiakkuus. Päihdelaskennat 1987–2003. Yhteiskuntapolitiikka 2004; 69(6):608–618 ( in Finnish).
- Hakkarainen P. Huumeiden käyttö Suomessa. Available at http://www.paihdelinkki.fi/tietoiskut/112-huumeiden-kaytto-suomessa. Last accessed on April 1, 2008 (in Finnish).
- European Monitoring Centre for Drugs and Drug Addiction. Summary and highlights. Annual report on the state of the drugs problem in the European Union. E.M.C.D.D.A. Luxembourg: Office for Official Publications of the European Communities, 1998. Available at http://www.emcdda.europa.eu/attachements.cfm/att_37349_EN_AR98highlightsEN.pdf. Last accessed on December 22, 2011.
- Statistics Finland. Population according to age (1-year) and gender by area 1980–2009. Available at http://pxweb2.stat.fi/database/StatFin/vrm/vaerak/vaerak_en.asp. Last accessed on December 22, 2011.
- Statistics Finland. Population according to age (5-year) and gender in the whole country 1865–2009. Available at http://pxweb2.stat.fi/database/StatFin/vrm/vaerak/vaerak_en.asp. Last accessed on December 22, 2011.
- Partanen P, Hakkarainen P, Holmström P, Kinnunen A, Lammi R, Leinikki P, Partanen A, Seppälä T, Simpura J, Virtanen A. Amfetamiinien ja opiaattien käytön yleisyys Suomessa 1998 (The prevalence of amphetamine and opiate use in Finland, 1998). Yhteiskuntapolitiikka 2000; 65(6):534–541 ( in Finnish).
- Hakkarainen P, Metso L. Huumekysymyksen muuttunut ongelmakuva. Vuoden 2006 huumekyselyn tulokset. Yhteiskuntapolitiikka 2007; 72(5):541–552 ( in Finnish).
- Salasuo M. Kokaiini Suomessa. Kirjassa. In Huumetilanne Suomessa 2006. Uusin tieto, uusimmat kehityssuuntaukset ja erityisteemat huumeista. Kansallinen seurantaraportti EMCDDA:lle. Rönkä S, Salonen P, eds. Helsinki: Stakes, 2006; 68–70.
- Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K, Pernet DE, Kirkbride JB, Murray GK, Bullmore ET, Jones PB. Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry 2007; 190:515–520.
- European Monitoring Centre for Drugs and Drug Addiction. Drug profiles. Available at http://www.emcdda.europa.eu/publications/drug-profiles. Last accessed on February 16, 2011.
- Lowinson JH, Ruiz P, Millman RB, Langrod JG. Substance Abuse. A Comprehensive Textbook (3rd ed.).Baltimore, MD: Williams & Wilkins, 1997.
- Scott R. Interventions to address violence associated with mental illness. Aust Psychiatry 2008; 16(6):405–411.
- Zhornitsky S, Rizkallah E, Pampoulova T, Chiasson JP, Stip E, Rompre PP, Potvin S. Antipsychotic agents for the treatment of substance use disorders in patients with and without comorbid psychosis. J Clin Psychopharmacol 2010; 30(4):417–424.
- Dalmau A, Bergman B, Brismar B. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness? Eur Psychiatry 1999; 14(7):366–371.
- Koskinen J, Löhönen J, Koponen H, Isohanni M, Miettunen J. Rate of cannabis use disorders in clinical samples of patients with Schizophrenia: A meta-analysis. Schizophr Bull 2010; 36(6):1115–1130 [Epub ahead of print].
- Fazel S, Gulati G, Linsell L, Geddes JR, Grann M. Schizophrenia and violence: Systematic review and meta-analysis. PLoS Med 2009; 6:e1000120.
- Viialainen R, Lehto J, eds. Sosiaali-ja terveyspalvelujen rakennemuutos. Laitoshoidon vähentämisestä avopalvelujen kehittämiseen. Raport no 192, 1996. The Ministry of Social Affairs and Health & STAKES (in Finnish).